US Stock MarketDetailed Quotes
BNGO Bionano Genomics
- 0.2191
- +0.0097+4.63%
Close Nov 21 16:00 ET
- 0.2197
- +0.0006+0.27%
Pre 06:15 ET
22.35MMarket Cap-95P/E (TTM)
0.2198High0.2000Low3.33MVolume0.2079Open0.2094Pre Close697.54KTurnover3.27%Turnover RatioLossP/E (Static)101.99MShares2.270052wk High0.46P/B22.30MFloat Cap0.200052wk Low--Dividend TTM101.77MShs Float156.9000Historical High--Div YieldTTM9.46%Amplitude0.2000Historical Low0.2090Avg Price1Lot Size
Bionano Genomics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -34.83%6.07M | -10.29%7.77M | 18.26%8.77M | 29.90%36.12M | 30.51%10.72M | 29.04%9.32M | 29.87%8.66M | 30.18%7.42M | 54.62%27.8M | 30.36%8.22M |
| Operating revenue | -34.83%6.07M | -10.29%7.77M | 18.26%8.77M | 29.90%36.12M | 30.51%10.72M | 29.04%9.32M | 29.87%8.66M | 30.18%7.42M | 54.62%27.8M | 30.36%8.22M |
| Cost of revenue | 121.02%14.52M | -18.38%5.19M | 11.23%5.95M | 21.47%26.55M | 29.22%8.28M | 21.38%6.57M | 22.22%6.35M | 10.55%5.35M | 54.94%21.86M | 5.72%6.41M |
| Gross profit | -407.24%-8.45M | 12.00%2.59M | 36.43%2.82M | 60.91%9.57M | 35.07%2.44M | 51.96%2.75M | 56.90%2.31M | 140.42%2.07M | 53.46%5.95M | 655.23%1.81M |
| Operating expense | -63.34%14.18M | -55.74%18.39M | -26.55%29.32M | 7.18%147.53M | -30.36%27.39M | 13.91%38.68M | 23.83%41.55M | 29.57%39.91M | 69.98%137.64M | 35.52%39.33M |
| Selling and administrative expenses | -61.99%9.46M | -57.09%11.56M | -24.79%19.54M | 5.53%93.5M | -38.04%15.69M | 17.35%24.9M | 23.66%26.94M | 28.11%25.98M | 51.47%88.6M | 27.84%25.32M |
| Research and development costs | -65.78%4.72M | -53.24%6.83M | -29.83%9.78M | 10.16%54.03M | -16.49%11.7M | 8.19%13.79M | 24.16%14.61M | 32.39%13.94M | 118.13%49.05M | 52.05%14.01M |
| Operating profit | 37.03%-22.63M | 59.73%-15.8M | 30.00%-26.49M | -4.76%-137.97M | 33.51%-24.95M | -11.77%-35.93M | -22.32%-39.24M | -26.38%-37.84M | -70.81%-131.7M | -30.38%-37.53M |
| Net non-operating interest income expense | -53.26%308K | -33.67%457K | 46.82%922K | -249.55%-1.81M | -633.67%-3.71M | 81.54%659K | 483.90%689K | 1,803.03%628K | 274.96%1.21M | 2,216.67%695K |
| Non-operating interest income | -48.49%376K | -33.67%457K | 48.30%1.04M | 119.71%3.31M | 54.42%1.19M | 67.43%730K | 258.85%689K | 540.00%704K | 538.56%1.51M | 816.67%770K |
| Non-operating interest expense | -4.23%68K | ---- | 60.53%122K | 1,617.79%5.12M | 6,430.67%4.9M | -2.74%71K | ---- | -1.30%76K | -67.85%298K | 38.89%75K |
| Other net income (expense) | 71.65%-21.9M | -158.18%-852K | -5,117.95%-5.87M | -41,450.67%-92.66M | -38,062.50%-15.27M | -1,545,180.00%-77.25M | -111.54%-330K | 454.55%117K | 38.06%-223K | -208.11%-40K |
| Gain on sale of security | ---630K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | 72.47%-21.27M | ---1.22M | ---4.63M | ---77.28M | --0 | ---77.28M | --0 | --0 | --0 | --0 |
| -Less：Restructuring and merger&acquisition | --1.77M | --1.22M | --4.63M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | -74.76%19.5M | ---- | ---- | --77.28M | --0 | --77.28M | ---- | ---- | --0 | --0 |
| Other non- operating income (expenses) | -96.15%1K | 210.00%363K | -1,158.97%-1.24M | -6,795.96%-15.38M | -38,062.50%-15.27M | 420.00%26K | -111.54%-330K | 454.55%117K | -277.97%-223K | -208.11%-40K |
| Income before tax | 60.70%-44.22M | 58.34%-16.2M | 15.25%-31.44M | -77.82%-232.43M | -19.13%-43.93M | -254.07%-112.53M | -21.05%-38.88M | -23.90%-37.1M | -67.25%-130.71M | -28.40%-36.87M |
| Income tax | -38.46%24K | -21.21%26K | -169.23%-18K | -96.71%62K | -101.99%-36K | 39.29%39K | -19.51%33K | 188.89%26K | 132.95%1.88M | 131.30%1.81M |
| Net income | 60.69%-44.25M | 58.31%-16.22M | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M |
| Net income continuous Operations | 60.69%-44.25M | 58.31%-16.22M | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 60.69%-44.25M | 58.31%-16.22M | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 60.69%-44.25M | 58.31%-16.22M | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M |
| Basic earnings per share | 83.85%-0.52 | 80.65%-2.4 | 51.22%-0.6 | -48.69%-6.81 | 26.24%-0.96 | -192.73%-3.22 | -9.73%-12.4 | -11.82%-1.23 | -76.15%-4.58 | -64.24%-1.3015 |
| Diluted earnings per share | 83.85%-0.52 | 80.65%-2.4 | 51.22%-0.6 | -48.69%-6.81 | 26.24%-0.96 | -192.73%-3.22 | -9.73%-12.4 | -11.82%-1.23 | -76.15%-4.58 | -64.24%-1.3015 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data